Cargando…

Progressive decline in circulating CNP with aging is associated with progressive cardiac fibrosis and myocardial impairment

Detalles Bibliográficos
Autores principales:	Sangaralingham, Jeson, Martin, Fernando L, McKie, Paul M, Ichiki, Tomoko, Mohammed, Selma F, Harders, Gerald E, Oehler, Elise A, Chen, Horng H, Redfield, Margaret M, Burnett, John C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313427/ http://dx.doi.org/10.1186/1471-2210-9-S1-S35

Ejemplares similares

Cenderitide, a novel dual GC-A and GC-B receptor activator, is a potent chronic cardiorenal fibroinhibiting peptide which suppresses aldosterone and reduces proteinuria in models of ardiorenal fibrosis
por: Martin, Fernando L, et al.
Publicado: (2011)

CD-NP: A Novel Engineered Dual Guanylyl Cyclase Activator with Anti-Fibrotic Actions in the Heart
por: Martin, Fernando L., et al.
Publicado: (2012)

M‐Atrial Natriuretic Peptide and Nitroglycerin in a Canine Model of Experimental Acute Hypertensive Heart Failure: Differential Actions of 2 cGMP Activating Therapeutics
por: McKie, Paul M., et al.
Publicado: (2014)

M-atrial natriuretic peptide and nitroglycerin in experimental acute hypertensive heart failure: differential actions of two cGMP activating therapeutics
por: McKie, Paul M, et al.
Publicado: (2013)

A novel designer natriuretic peptide CD-NP suppresses TGF-beta 1 induced collagen Type I production in human cardiac fibroblasts
por: Ichiki, Tomoko, et al.
Publicado: (2009)

Early activation of deleterious molecular pathways in the kidney in experimental heart failure with atrial remodeling
por: Ichiki, Tomoko, et al.
Publicado: (2017)

C-Type natriuretic peptide: a potential urinary biomarker for renal remodeling and fibrosis during aging
por: Sangaralingham, Jeson S, et al.
Publicado: (2011)

Lessons from tissue-specific KO of CNP/GC-B system - everlasting challenge to clinical application
por: Nakao, Kazuwa, et al.
Publicado: (2013)

Natriuretic peptide pathways in heart failure: further therapeutic possibilities
por: Sangaralingham, S Jeson, et al.
Publicado: (2022)

Cardiac Versus Renal Response to Volume Expansion in Preclinical Systolic Dysfunction With PDEV Inhibition and BNP
por: Wan, Siu-Hin, et al.
Publicado: (2019)

C-type natriuretic peptide: the heart’s guardian angel
por: Sangaralingham, S Jeson, et al.
Publicado: (2020)

A Human Study to Evaluate Safety, Tolerability, and Cyclic GMP Activating Properties of Cenderitide in Subjects With Stable Chronic Heart Failure
por: Kawakami, Rika, et al.
Publicado: (2018)

Mutation of three amino acids in the disulfide-ring of a CNP based chimeric natriuretic peptide alters its vascular properties
por: Chen, Horng H, et al.
Publicado: (2009)

Comparative measurement of CNP and NT-proCNP in human blood samples: a methodological evaluation
por: Kuehnl, Andreas, et al.
Publicado: (2013)

Genetic variants of ANP and cardiometabolic protection: from populations to novel therapeutics
por: Cannone, Valentina, et al.
Publicado: (2013)

Treatment with CBA-NP a novel chimeric natriuretic peptide attenuates cardiorenal fibrosis and improves diastolic dysfunction in diabetic rat model
por: Ameenuddin, Syed, et al.
Publicado: (2011)

Therapeutic potential of CNP for skeletal dysplasias
por: Yasoda, Akihiro, et al.
Publicado: (2009)

Chronic natriuretic peptide protein therapeutics
por: Chen, Horng H, et al.
Publicado: (2013)

CNP Signal Peptide in Patients with Cardiovascular Disease
por: Lee, Jacqui, et al.
Publicado: (2015)

Uncovering oligodendrocyte enhancers that control Cnp expression
por: Fan, Chuandong, et al.
Publicado: (2023)

Progress and Decline of the Epidemic
Publicado: (1849)

The alteration of NTproCNP plasma levels following anaerobic exercise in physically active young men
por: Temür, Hilal Akseki, et al.
Publicado: (2015)

MANP: a novel particulate guanylyl cyclase A receptor/cGMP activator for resistant hypertension: preliminary first in human clinical trial results
por: Burnett, John C, et al.
Publicado: (2015)

Effects of phosphodiesterase V inhibition alone and in combination with BNP on cardiovascular and renal response to volume load in human preclinical diastolic dysfunction
por: Wan, Siu‐Hin, et al.
Publicado: (2021)

Early stage chronic kidney disease: a paradigm for diffuse fibrosis and clinical progression
por: Edwards, Nicola C, et al.
Publicado: (2014)

Any progress for HIV vaccines to come?
por: Wigzell, Hans
Publicado: (2006)

Clinical translation of progress in molecular endocrinology
por: Dowsett, M
Publicado: (2000)

PSP and NT-proCNP assessed for predisposition to infection
por: Lajaunias, Frederic
Publicado: (2013)

CNP Promotes Antiarrhythmic Effects via Phosphodiesterase 2
por: Cachorro, Eleder, et al.
Publicado: (2023)

Cyclic nucleotide phosphodiesterases – 40 years of progress
por: Beavo, Joseph A, et al.
Publicado: (2009)

Recent progress in genetics of adolescent idiopathic scoliosis
por: Elbakry, Mohamed, et al.
Publicado: (2010)

The role of the tumor microenvironment in breast cancer progression
por: Min, H, et al.
Publicado: (2005)

Melanoma progression is associated with NK cell exhaustion
por: Pires da Silva, Ines, et al.
Publicado: (2014)

Quantitative analysis of structural abnormality of the vestibular system in progressive and non-progressive adolescent idiopathic scoliosis (AIS) using MRI techniques
por: Chu, Winnie CW, et al.
Publicado: (2015)

A biodegradable in-situ polymer precipitation delivery system for sustained delivery of a novel chimeric natriuretic peptide CD-NP in an experimental model of myocardial infarction
por: Lim, Soo Ghim, et al.
Publicado: (2013)

Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction
por: AbouEzzeddine, Omar F., et al.
Publicado: (2017)

The German plan for rare diseases: a development in progress
por: Graf von der Schulenburg, Johann Mathias
Publicado: (2010)

Tumor microenvironment controls the rate of cancer progression and metastasis
por: Kalluri, Raghu
Publicado: (2010)

Progress in the development of Reversed Chloroquine molecules as antimalarial therapy
por: Burgess, Steven J, et al.
Publicado: (2010)

Convex side muscular activity and progression of scoliotic curve
por: Rusovs, Gundars, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_e254617g1jo25m3k3pgrafmjeg